
| ASSET | DATE | % RETURN |
|---|---|---|
Netflix (NFLX) | 9/1/2012 - 10/31/2015 | 1,208.04% |
Genmab A-S (GMAB) | 9/1/2012 - 10/31/2015 | 841.29% |
Tesla (TSLA) | 9/1/2012 - 10/31/2015 | 625.57% |
Neurocrine Biosciences (NBIX) | 9/1/2012 - 10/31/2015 | 566.98% |
DexCom (DXCM) | 9/1/2012 - 10/31/2015 | 524.12% |
Insmed (INSM) | 9/1/2012 - 10/31/2015 | 510.46% |
Delta Air Lines (DAL) | 9/1/2012 - 10/31/2015 | 499.07% |
Incyte (INCY) | 9/1/2012 - 10/31/2015 | 487.36% |
Trip Group Ltd ADR (TCOM) | 9/1/2012 - 10/31/2015 | 477.81% |
Manhattan Associates (MANH) | 9/1/2012 - 10/31/2015 | 475.32% |
Facebook (META) | 9/1/2012 - 10/31/2015 | 463.99% |
Electronic Arts (EA) | 9/1/2012 - 10/31/2015 | 445.16% |
Southwest Airlines (LUV) | 9/1/2012 - 10/31/2015 | 430.11% |
Celsius (CELH) | 9/1/2012 - 10/31/2015 | 405.13% |
Alnylam Pharmaceuticals (ALNY) | 9/1/2012 - 10/31/2015 | 369.16% |
Axon Enterprise (AXON) | 9/1/2012 - 10/31/2015 | 337.57% |
Tyler Technologies (TYL) | 9/1/2012 - 10/31/2015 | 326.65% |
Diamondback Energy (FANG) | 9/1/2012 - 10/31/2015 | 314.37% |
Constellation Brands Inc Class A (STZ) | 9/1/2012 - 10/31/2015 | 310.11% |
Royal Caribbean Cruises (RCL) | 9/1/2012 - 10/31/2015 | 282.36% |
Gilead Sciences (GILD) | 9/1/2012 - 10/31/2015 | 278.89% |
Regeneron Pharmaceuticals (REGN) | 9/1/2012 - 10/31/2015 | 275.6% |
Broadcom (AVGO) | 9/1/2012 - 10/31/2015 | 257.93% |
Kroger (KR) | 9/1/2012 - 10/31/2015 | 255.6% |
Ionis Pharmaceuticals (IONS) | 9/1/2012 - 10/31/2015 | 251.97% |